Translating the discoveries made by Faculty researchers into new diagnostic modalities and treatments for patients and generating genuine clinical impact is a key part of the Faculty’s mission. In this context, partnership with leading companies such as GSK are crucial and I am delighted to see this innovative joint appointment as a component of our strategic alliance.
Professor Ajay Shah, Executive Dean, Faculty of Life Sciences & Medicine
05 May 2022
Professor Tony Ng to join GSK following long-standing collaboration
Professor Tony Ng, School of Cancer & Pharmaceutical Sciences, will be joining GSK later this month on a part-time basis, to help establish the GSK-KCL Translational Oncology Research Hub which was which was announced in September 2021.
This collaboration between King’s and GSK looks to use AI-ML and advanced biological signatures to personalise cancer treatments, by developing a platform based on 3D tumour models, tissue imaging, and multi-omic data.
Tony will be focusing primarily on building a dedicated lab to generate biological and digital response predictions in order to better stratify patient populations for oncology clinical trials. This work will shed light on the individualised needs of cancer patients, and will complement and enhance the projects that Tony and his team are working on at King’s.
Tony will remain as Joint Head of the School of Cancer & Pharmaceutical Sciences, in addition to retaining his role as BRC Cancer theme lead designate.
This is a unique professional opportunity for me to enhance the translation of the excellent clinical and translational science that we have within KCL and its hospital partners, through innovative trial design with scientific endpoints and advanced analytics (e.g. AI), into tangible benefits for cancer patients. By combining my Cancer Centre responsibilities and this new additional role in GSK, I aim to contribute to building a deeper relationship between KHP and industry, working towards our shared goal of improving cancer patient outcome.
Professor Tony Ng
In this story
Richard Dimbleby Professor of Cancer Research